VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $25,795,000 | +46.1% | 1,108,902 | -0.1% | 0.04% | +44.4% |
| Q1 2018 | $17,650,000 | -25.1% | 1,109,502 | -1.5% | 0.03% | -20.6% |
| Q4 2017 | $23,562,000 | +39.3% | 1,126,802 | -4.7% | 0.03% | +36.0% |
| Q3 2017 | $16,911,000 | -23.2% | 1,182,902 | -6.7% | 0.02% | -28.6% |
| Q2 2017 | $22,007,000 | +49.4% | 1,268,002 | -5.2% | 0.04% | +52.2% |
| Q1 2017 | $14,732,000 | -29.9% | 1,337,502 | -7.6% | 0.02% | -34.3% |
| Q4 2016 | $21,020,000 | -42.0% | 1,447,802 | -2.1% | 0.04% | -44.4% |
| Q3 2016 | $36,218,000 | +17.4% | 1,478,702 | -3.9% | 0.06% | +12.5% |
| Q2 2016 | $30,857,000 | -26.3% | 1,538,352 | -3.3% | 0.06% | -28.2% |
| Q1 2016 | $41,886,000 | -78.7% | 1,591,150 | -18.2% | 0.08% | -80.1% |
| Q4 2015 | $196,885,000 | -49.8% | 1,944,449 | -11.8% | 0.39% | -49.4% |
| Q3 2015 | $391,892,000 | -20.4% | 2,204,505 | -0.6% | 0.77% | -12.2% |
| Q2 2015 | $492,345,000 | +11.4% | 2,218,178 | -0.8% | 0.88% | +10.2% |
| Q1 2015 | $442,008,000 | +41.0% | 2,235,906 | +2.4% | 0.80% | +52.9% |
| Q4 2014 | $313,397,000 | +7.0% | 2,183,119 | -2.1% | 0.52% | +3.4% |
| Q3 2014 | $292,795,000 | +12.8% | 2,229,911 | +8.8% | 0.50% | +14.3% |
| Q2 2014 | $259,650,000 | -1.3% | 2,050,437 | +2.7% | 0.44% | -7.7% |
| Q1 2014 | $263,126,000 | +13.7% | 1,996,789 | +1.3% | 0.48% | +10.9% |
| Q4 2013 | $231,325,000 | +13.6% | 1,972,094 | +1.2% | 0.43% | +6.7% |
| Q3 2013 | $203,617,000 | +31.7% | 1,949,039 | +8.4% | 0.40% | +22.0% |
| Q2 2013 | $154,605,000 | – | 1,798,422 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |